Oral carriage of Candida albicans in murine AIDS

Infection and Immunity

Volumn 65, Issue 2, 1997, Pages 661-667

  Deslauriers, Noëlla ^a   Côté, Ludger ^a   Montplaisir, Serge ^b   De Repentigny, Louis ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE CELL; MOUSE; MOUTH INFECTION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

EID: 1842369135     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.2.661-667.1997     Document Type: Article

References (52)

1. Arendorf, T. M., and D. M. Walker. 1980. The prevalence and intra-oral distribution of C. albicans in man. Arch. Oral Biol. 25:1-10.
2. Ascher, M. S., and H. W. Sheppard. 1988. AIDS as immune system activation, a model for pathogenesis. Clin. Exp. Immunol. 73:165-167.
3. Ashman, R. B., and J. M. Papadimitriou. 1995. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59:646-672.
4. Aziz, D. C., Z. Hanna, and P. Jolicoeur. 1989. Severe immunodeficiency disease induced by a defective murine leukemia virus. Nature 338:505-508.
5. Balish, E., H. Filutowicz, and T. D. Oberley. 1990. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun. 58:107-113.
6. Balish, E., J. Jensen, T. Warner, J. Brekke, and B. Leonard. 1993. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J. Med. Vet. Mycol. 31:143-154.
7. Benton, J., C. D. Tsoukis, J. A. McCutchan, S. A. Spector, D. D. Richman, and J. H. Vaughan. 1989. Impairment in T-lymphocyte responses during early infection with human immunodeficiency virus. J. Clin. Immunol. 9:159-168.
8. Buller, R. M. L., R. A. Yetter, T. N. Fredrickson, and H. C. Morse III. 1987. Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J. Virol. 61:383-387.
9. Cantorna, M. T., and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100.
10. + lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:2447-2455.
11. Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K.-H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type 1 (Th1)-and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279-1288.
12. Centers for Disease Control and Prevention. 1993. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41:1-19.
13. Chakir, J., L. Côté, C. Coulombe, and N. Deslauriers. 1994. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 mice. Oral Microbiol. Immunol. 9:88-94.
14. Christmas, S. E., and A. Meager. 1990. Production of IFN-γ and TNF-α by human T-cell clones expressing different forms of the γδ receptor. Immunology 71:486-497.
15. H2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
16. Cole, G. T., K. Saha, K. R. Seshan, K. T. Lynn, M. Franco, and P. K. Y. Wong. 1992. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect. Immun. 60:4168-4178.
17. + treated mice. Immunol. Infect. Dis. 4:219-227.
18. Deslauriers, N., C. Coulombe, B. Carré, and J. P. Goulet. 1995. Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of C. albicans. FEMS Immunol. Med. Microbiol. 11:45-56.
19. Dodd, C. L., D. Greenspan, M. H. Katz, J. L. Westenhouse, D. W. Feigal, and J. S. Greenspan. 1991. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 5:1339-1343.
20. Dull, J. S., P. Sen, S. Raffanti, and J. R. Middleton. 1991. Oral candidiasis as a marker of acute retroviral illness. South. Med. J. 84:733-735.
21. Dupont, B., D. W. Denning, D. Marriott, A. Sugar, M. A. Viviani, and T. Sirisanthana. 1993. Mycoses in AIDS patients. J. Med. Vet. Mycol. 32 (Suppl. 1):65-77.
22. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus diseases: implications for therapy. Science 262:1011-1018.
23. H1 pattern of cytokines. J. Immunol. 144:1744-1750.
24. Fortier, C., J. Barbeau, and N. Deslauriers. 1990. Mast cells in the murine oral mucosa are of the connective tissue type. Reg. Immunol. 3:35-41.
25. Gazzinelli, R. T., J. W. Hartley, T. N. Fredrickson, S. K. Chattopadhyay, A. Sher, and H. C. Morse III. 1992. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Taxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect. Immun. 60:4394-4401.
26. H2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 148:182-188.
27. Hartley, J. W., T. N. Fredrickson, R. A. Yetter, M. Makino, and H. C. Morse III. 1989. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1223-1231.
28. Hugin, A. W., A. Cerny, and H. C. Morse. 1994. Mice with an acquired immunodeficiency (MAIDS) develop a persistent infection after infection with Listeria monocytogenes. Cell. Immunol. 155:246-252.
29. Jensen, J., T. Warner, and E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912-919.
30. Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170:900-905.
31. Jolicoeur, P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study AIDS pathogenesis. FASEB J. 5:2398-2405.
32. Jones-Carson, J., A. Vasquez-Torres, H. C. van der Heyde, T. Warner, R. D. Wagner, and E. Balish. 1995. γ/δ T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med. 1:552-557.
33. Katlama, C., and G. M. Dickinson. 1993. Update on opportunistic infections. AIDS 7:203-209.
34. Klinman, D. M., and H. C. Morse. 1989. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1144-1149.
35. Lacasse, M., C. Fortier, J. Chakir, L. Côté, and N. Deslauriers. 1993. Acquired resistance and persistence of C. albicans following oral candidiasis in the mouse: a model of the carrier state in humans. Oral Microbiol. Immunol. 8:312-317.
36. Makino, M., D. F. Winkler, J. Wunderlich, J. W. Hartley, H. C. Morse, and K. L. Holmes. 1993. High expression of NK-1.1 antigen is induced by infection with murine AIDS virus. Immunology 80:319-325.
37. Mathews, H. L., and L. J. Witek-Janusek. 1996. Local lymphoid response to active infection with Candida albicans, abstr. F-92, p. 89. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington. D.C.
38. Mencacci, A., E. Cenci, R. Spaccapelo, L. Tonnetti, L. Romani, P. Puccetti, and F. Bistoni. 1995. Rationale for cytokine and anti-cytokine therapy of Candida albicans infection. J. Mycol. Med. 5:25-30.
39. Mosier, D. E. 1986. Animal models for retrovirus-induced immunodeficiency disease. Immunol. Invest. 15:233-261.
40. Mossman, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65:55-63.
41. Muralidhar, G., S. Koch, M. Haas, and S. L. Swain. 1992. CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J. Exp. Med. 175:1589-1599.
42. Orme, I. M., S. K. Furney, and A. D. Roberts. 1992. Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses. Infect. Immun. 60:4747-4753.
43. Pantaleo, G., and A. S. Fauci. 1994. Tracking HIV during disease progression. Curr. Opin. Immunol. 6:600-604.
44. Pitha, P. M., D. Biegel, R. A. Yetter, and H. C. Morse III. 1988. Abnormal regulation of IFNα, β and γ expression in MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J. Immunol. 141:3611-3616.
45. Rodrigue, L., D. Marion, L. Trudel, C. Barthe, and M. C. Lavoie. 1989. Comparison of methods for the evaluation of the oral microbiota of mice. J. Microbiol. Methods 10:71-82.
46. H2 responses in AIDS. Curr. Opin. Immunol. 6:616-622.
47. Romani, L., S. Mocci, C. Bietta, L. Lanfaloni, P. Puccetti, and F. Bistoni. 1991. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59:4647-4654.
48. Royce, R. A., R. S. Luckman, R. E. Fusaro, and W. J. Wilkensteen. 1991. The natural history of HIV-1 infection: staging classifications of disease. AIDS 5:355-364.
49. Saah, A. J., A. Munoz, V. Kuo, R. Fox, R. A. Kaslow, J. P. Phair, C. R. Rinaldo, R. Detels, and B. F. Polk. 1992. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study. Am. J. Epidemiol. 135:1147-1155.
50. Samaranayake, L. P. 1990. Host factors and oral candidiasis, p. 66-103. In L. P. Samaranayake and T. W. MacFarlane (ed.), Oral candidosis. Wright, London.
51. Sher, A., and R. L. Coffman. 1991. Regulation of immunity to parasites by T cells and T-cell derived cytokines. Annu. Rev. Immunol. 10:385-432.
52. Van Noesel, C. J. M., R. A. Gruters, F. G. Terstra, P. T. H. A. Schellenkens, R. A. W. van Lier, and F. Miedema. 1990. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest. 86:293-299.